Century Therapeutics Inc.

0.61
-0.07 (-10.66%)
At close: Mar 03, 2025, 3:59 PM
0.64
4.88%
After-hours: Mar 03, 2025, 04:44 PM EST

Century Therapeutics Ratios Statement

Year FY23 FY22 FY21 FY20 FY19
PE Ratio -1.44 -2.26 -9.1 -22.9 -5.09
PEG Ratio -1.09 -0.07 -0.12 0.29 n/a
PS Ratio 88.11 56.99 n/a n/a n/a
PB Ratio 1.07 0.98 2.20 -11.76 -13.63
P/FCF Ratio -1.93 -17.9 -6.51 -24.5 -67.19
P/OCF Ratio -2.23 21.09 -9.8 -30.33 -77.42
OCF/S Ratio -39.53 2.70 n/a n/a n/a
Debt / Equity Ratio 0.26 0.16 0.06 -0.2 n/a
Quick Ratio 9.92 10.72 14.59 6.35 27.32
Current Ratio 9.92 10.72 14.57 6.51 28.10
Asset Turnover 0.01 0.01 n/a n/a n/a
Interest Coverage -271.38 -121.11 -74.42 -141.46 n/a
Return on Equity (ROE) -0.74 -0.43 -0.24 0.51 2.68
Return on Assets (ROA) -0.38 -0.27 -0.22 -0.51 -2.71
Return on Capital (ROIC) -0.43 -0.29 -0.22 -0.57 -2.8
Dividend Yield n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a
Gross Profit Margin -483.62% -93.71% n/a n/a n/a
Net Profit Margin -6.12K% -2.52K% n/a n/a n/a
Pretax Profit Margin -6.03K% -2.52K% n/a n/a n/a
Operating Profit Margin -6.56K% -2.57K% n/a n/a n/a
FCF Margin -4.57K% -318.37% n/a n/a n/a
EBITDA Margin -5.42K% -2.3K% n/a n/a n/a